- Home
- CAMT vs RYTM Comparison
CAMT vs RYTM Comparison
Compare CAMT & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAMT
- RYTM
- Stock Information
- Founded
- CAMT 1987
- RYTM 2008
- Country
- CAMT Israel
- RYTM United States
- Employees
- CAMT N/A
- RYTM N/A
- Industry
- CAMT Electronic Components
- RYTM Biotechnology: Pharmaceutical Preparations
- Sector
- CAMT Technology
- RYTM Health Care
- Exchange
- CAMT Nasdaq
- RYTM Nasdaq
- Market Cap
- CAMT 3.9B
- RYTM 3.5B
- IPO Year
- CAMT 2000
- RYTM 2017
- Fundamental
- Price
- CAMT $76.39
- RYTM $56.07
- Analyst Decision
- CAMT Strong Buy
- RYTM Strong Buy
- Analyst Count
- CAMT 8
- RYTM 10
- Target Price
- CAMT $113.38
- RYTM $66.90
- AVG Volume (30 Days)
- CAMT 674.6K
- RYTM 380.5K
- Earning Date
- CAMT 02-12-2025
- RYTM 02-26-2025
- Dividend Yield
- CAMT 1.74%
- RYTM N/A
- EPS Growth
- CAMT 48.32
- RYTM N/A
- EPS
- CAMT 2.42
- RYTM N/A
- Revenue
- CAMT $429,234,000.00
- RYTM $112,530,000.00
- Revenue This Year
- CAMT $16.55
- RYTM $66.58
- Revenue Next Year
- CAMT $10.88
- RYTM $44.63
- P/E Ratio
- CAMT $33.01
- RYTM N/A
- Revenue Growth
- CAMT 36.10
- RYTM 81.55
- 52 Week Low
- CAMT $69.83
- RYTM $35.17
- 52 Week High
- CAMT $140.50
- RYTM $68.58
- Technical
- Relative Strength Index (RSI)
- CAMT 34.70
- RYTM 42.18
- Support Level
- CAMT $83.22
- RYTM $56.03
- Resistance Level
- CAMT $90.50
- RYTM $58.65
- Average True Range (ATR)
- CAMT 4.99
- RYTM 1.87
- MACD
- CAMT -1.65
- RYTM -0.27
- Stochastic Oscillator
- CAMT 10.25
- RYTM 5.45
About CAMT Camtek Ltd.
Camtek Ltd is engaged in the manufacturing of metrology and inspection equipment and software solutions for the semiconductor industry. Its systems inspect wafers for various semiconductor market segments, including Advanced Packaging, Heterogenous Integration (HI), Compound Semiconductors, Memory, and foundries among others. Geographically, it derives maximum revenue from China followed by Asia Pacific, Korea, United States, and Europe. The company's products and services include Surface Inspection, Bump Inspection and Metrology, and others.
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies. Geographically the company generates its revenue from the United states, Germany, and other with the majority being generated from the United states.